Healthcare Services

Advancements in D-dimer testing are improving accuracy and driving market growth

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The D Dimer Testing Market Over The 2026–2030 Period?

The d dimer testing market has experienced robust expansion over recent years. This market is projected to expand from $1.54 billion in 2025 to $1.62 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. Historically, this expansion has been driven by factors such as the significant occurrence of thrombotic disorders, prevalence of hospital-based laboratory testing, dependence on ELISA methods, urgent diagnostic requirements, and restricted availability of rapid testing options.

The d dimer testing market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $2.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. This projected increase can be ascribed to several factors, including the proliferation of point-of-care diagnostics, a heightened prevalence of cardiovascular diseases, innovations in immunoassay technology, the need for quicker results, and the broadening scope of decentralized testing. Key developments expected during this timeframe encompass a greater embrace of point-of-care testing, augmented application in emergency diagnostic scenarios, the spread of automated laboratory analyzers, an increase in rapid testing kits, and their incorporation into established clinical decision pathways.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Which Major Drivers Are Influencing The Expansion Of The D Dimer Testing Market?

The expanding occurrence of cancer is projected to boost the growth of the d-dimer testing market. Cancer refers to a group of diseases where abnormal cells multiply uncontrollably in various body parts, potentially spreading or invading nearby tissues. D-dimer testing plays a crucial role in assisting with the diagnosis, monitoring, and treatment of cancer patients, as well as evaluating the risk of blood clot formation and tracking thrombotic events across different clinical scenarios. As an illustration, the National Cancer Institute (NCI), a US-based government body focused on cancer research and education, reported that in May 2025, approximately 2,041,910 new cancer cases are anticipated to be diagnosed in the United States in 2025, leading to an estimated 618,120 deaths from the illness. For men, prostate, lung, and colorectal cancers are expected to comprise around 48% of all new cancer diagnoses, while for women, breast, lung, and colorectal cancers will make up about 51% of all new cases. Furthermore, in 2025, an estimated 14,690 children and adolescents aged 0 to 19 are expected to receive a cancer diagnosis, with 1,650 projected to die from the disease. Consequently, the rising prevalence of cancer is a significant factor driving the expansion of the d-dimer testing market.

How Is The D Dimer Testing Market Categorized Across Its Segment Groups?

The d dimer testing market covered in this report is segmented –

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests

2) By Product: Analyzers, Reagents And Consumables

3) By Method: Enzyme-Linked Immunosorbent Assay (ELISA), Latex-Enhanced Immuno-Turbidimetric Assays, Fluorescence Immunoassays, Other Testing Methods

4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications

5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-Users

Subsegments:

1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays

2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays

Which Trends Are Shaping The D Dimer Testing Market?

Companies operating in the d-dimer testing market are actively developing innovative products, such as the D-dimer test kit, to enhance the accuracy and speed of diagnosing blood clot-related conditions. A D-dimer test kit serves as a medical diagnostic tool designed to measure D-dimer levels, a fibrin degradation product, in the blood, thereby aiding in the assessment of blood clots and conditions like deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. For example, in July 2024, Bionote Inc., a South Korea-based medical equipment manufacturing company, launched its Vcheck D-dimer 5Tests/Kit. This new D-dimer 5-Test Kit for Vcheck immunodiagnostic equipment has been introduced, specifically tailored for veterinary clinics. The kit assists in diagnosing conditions such as thrombosis and DIC, making it an ideal solution for smaller clinics with a lower volume of emergency cases.

Which Firms Are Influencing Competition In The D Dimer Testing Market?

Major companies operating in the d dimer testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

Get The Full D Dimer Testing Market Report:

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Which Region Is The Largest In The D Dimer Testing Market?

North America was the largest region in the D dimer testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the d dimer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized D Dimer Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Browse Through More Reports Similar to the Global D Dimer Testing Market 2026, By The Business Research Company

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Dimer Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/dimer-acid-global-market-report

Dimethyl Ether Market Report 2026

https://www.thebusinessresearchcompany.com/report/dimethyl-ether-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795